NovoCure Ltd. (NVCR)
13.06
-0.26
(-1.95%)
USD |
NASDAQ |
Dec 15, 15:41
NovoCure Free Cash Flow: -65.17M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| LivaNova Plc | 191.43M |
| Perspective Therapeutics, Inc. | -106.85M |
| Xtant Medical Holdings, Inc. | 5.123M |
| VolitionRX Ltd. | -19.64M |
| Catheter Precision, Inc. | -9.721M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 20.57M |
| Cash from Investing (Quarterly) | 71.44M |
| Cash from Financing (Quarterly) | 100.52M |
| Free Cash Flow Per Share (Quarterly) | 0.1333 |
| Free Cash Flow to Equity (Quarterly) | -82.77M |
| Free Cash Flow to Firm (Quarterly) | 14.92M |
| Free Cash Flow Yield | -4.51% |